# Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women

> **NCT01532115** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 64 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** BIA 9-1067
- **DRUG:** Placebo
- **DRUG:** moxifloxacin

## Key facts

- **NCT ID:** NCT01532115
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2011-05
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2012-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01532115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01532115, "Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT01532115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*